142 related articles for article (PubMed ID: 28554701)
1. [Development of a risk calculator for drug compliance in treated hypertensives: The FLAHS Compliance Calculator].
Girerd X; Hanon O; Pannier B; Vaïsse B
Ann Cardiol Angeiol (Paris); 2017 Jun; 66(3):149-153. PubMed ID: 28554701
[TBL] [Abstract][Full Text] [Related]
2. [Use of the EvalObs
Girerd X; Hanon O; Vaïsse B
Ann Cardiol Angeiol (Paris); 2018 Jun; 67(3):186-190. PubMed ID: 29786508
[TBL] [Abstract][Full Text] [Related]
3. [Determinants of controlled hypertension in patients treated with antihypertensive drugs in France: The French League Against Hypertension Survey (FLAHS 2015)].
Girerd X; Hanon O; Pannier B; Mourad JJ; Vaïsse B
Ann Cardiol Angeiol (Paris); 2016 Jun; 65(3):219-22. PubMed ID: 27199204
[TBL] [Abstract][Full Text] [Related]
4. [Estimation of the number of patients treated for hypertension, diabetes or hyperlipidemia in France: FLAHS study 2002].
Girerd X; Mourad JJ; Vaïsse B; Poncelet P; Mallion JM; Herpin D
Arch Mal Coeur Vaiss; 2003; 96(7-8):750-3. PubMed ID: 12945216
[TBL] [Abstract][Full Text] [Related]
5. [Trends in the use of antihypertensive drugs in France from 2002 to 2012: FLAHS surveys].
Girerd X; Hanon O; Pannier B; Vaïsse B; Mourad JJ
Ann Cardiol Angeiol (Paris); 2013 Jun; 62(3):210-4. PubMed ID: 23759733
[TBL] [Abstract][Full Text] [Related]
6. [Hypertension in the elderly in France: Characteristics of treatments and frequency of cognitive complaint according to the 2014 French League against Hypertension Survey].
Girerd X; Hanon O; Pannier B; Mourad JJ; Vaïsse B
Ann Cardiol Angeiol (Paris); 2015 Jun; 64(3):145-9. PubMed ID: 26044309
[TBL] [Abstract][Full Text] [Related]
7. Sex differences in adherence to antihypertensive treatment in patients aged above 55: The French League Against Hypertension Survey (FLAHS).
Lefort M; Neufcourt L; Pannier B; Vaïsse B; Bayat S; Grimaud O; Girerd X
J Clin Hypertens (Greenwich); 2018 Oct; 20(10):1496-1503. PubMed ID: 30238630
[TBL] [Abstract][Full Text] [Related]
8. [Number and use of home blood pressure devices in France in 2004 and 2006 (FLAHS 2006)].
Herpin D; Mourad JJ; Postel-Vinay N; Pannier B; Vaïsse B; Girerd X;
Arch Mal Coeur Vaiss; 2007 Aug; 100(8):620-4. PubMed ID: 17928763
[TBL] [Abstract][Full Text] [Related]
9. [Use of antihypertensive drugs in France and relationship with cardiovascular disease. FLAHS 2009-2010 surveys].
Girerd X; Laroche P; Hanon O; Pannier B; Postel-Vinay N; Mourad JJ
Ann Cardiol Angeiol (Paris); 2012 Jun; 61(3):213-7. PubMed ID: 22695024
[TBL] [Abstract][Full Text] [Related]
10. The repercussion of stopping reimbursement of olmésartan on antihypertensive drugs prescription and blood pressure control of treated hypertensive patients in France.
Dufay A; Gallo A; Hanon O; Vaïsse B; Girerd X
Ann Cardiol Angeiol (Paris); 2018 Jun; 67(3):149-153. PubMed ID: 29807620
[TBL] [Abstract][Full Text] [Related]
11. [Assessment of antihypertensive monotherapies effectiveness by home blood pressure self-measurement in hypertensive patients].
Hanon O; Laroche P; Vidal JS; Pannier B; Postel-Vinay N; Vaisse B; Girerd X
Ann Cardiol Angeiol (Paris); 2012 Jun; 61(3):218-23. PubMed ID: 22695025
[TBL] [Abstract][Full Text] [Related]
12. Factors associated with poor medication compliance in hypertensive patients.
Mzoughi K; Zairi I; Jemai A; Ben Kilani M; Ben Daamar H; Ben Gaied Hassine E; Kraiem S
Tunis Med; 2018 Jun; 96(6):385-390. PubMed ID: 30430478
[TBL] [Abstract][Full Text] [Related]
13. [Changes in life style and drug therapy for treatment of hypertension in France between 2002 and 2004].
Girerd X; Herpin D; Postel-Vinay N; Vaïsse B; Poncelet P; Mallion JM; Murino M; Mourad JJ
Arch Mal Coeur Vaiss; 2005; 98(7-8):813-6. PubMed ID: 16220753
[TBL] [Abstract][Full Text] [Related]
14. Trends in population blood pressure and determinant factors for population blood pressure.
Andersen UO
Dan Med J; 2017 Mar; 64(3):. PubMed ID: 28260600
[TBL] [Abstract][Full Text] [Related]
15. [Use of home blood pressure devices in France in 2004].
Mourad JJ; Herpin D; Postel-Vinay N; Vaïsse B; Poncelet P; Mallion JM; Murino M; Girerd X
Arch Mal Coeur Vaiss; 2005; 98(7-8):779-82. PubMed ID: 16220747
[TBL] [Abstract][Full Text] [Related]
16. [Effect of the presence of a drug in the list of supplementary drug provision on compliance to its administration by outpatients with arterial hypertension].
Ageev FT; Fofanova TV; Kadushina EB; Deev AD; Kuz'mina AE; Patrusheva IF
Kardiologiia; 2011; 51(6):21-5. PubMed ID: 21878066
[TBL] [Abstract][Full Text] [Related]
17. The CAPITAL study (CArdiovascular Prevention wIth Telecardiology in ApuLia): preliminary results.
Brunetti ND; Lanzone S; Dellegrottaglie G; Di Giuseppe G; De Gennaro L; Novielli V; Straziota E; Loiacono T; Di Biase M
J Cardiovasc Med (Hagerstown); 2016 Jul; 17(7):455-61. PubMed ID: 26308713
[TBL] [Abstract][Full Text] [Related]
18. Impact of a better adherence to antihypertensive agents on cerebrovascular disease for primary prevention.
Kettani FZ; Dragomir A; Côté R; Roy L; Bérard A; Blais L; Lalonde L; Moreau P; Perreault S
Stroke; 2009 Jan; 40(1):213-20. PubMed ID: 19038916
[TBL] [Abstract][Full Text] [Related]
19. Appraisal of the Knowledge of Hypertensive Patients Regarding Blood Pressure Control and Comorbidities: Results of a French Regional Survey.
Allibe M; Babici D; Chantrel YF; Lesquerbault B; Dubau M; Fickl R; Takla Z; Preissig-Dirhold C; Bucura R; Sissoko A; Coliban M; Chantrel F
High Blood Press Cardiovasc Prev; 2016 Dec; 23(4):365-372. PubMed ID: 27826733
[TBL] [Abstract][Full Text] [Related]
20. Medication adherence in hypertensive patients of different cardiovascular risk treated in primary health care.
Wiliński J; Dabrowski M
Przegl Lek; 2013; 70(6):377-80. PubMed ID: 24052973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
